A dyadic analysis of financial toxicity and health-related quality of life among bone marrow transplant patients and their caregivers.

Objective: Relatively few dyad-based studies have evaluated the shared psychosocial and financial toxicity (FT) experiences of hematologic patients and their caregivers, especially those undergoing bone marrow transplantations (BMTs). This study evaluated the association of FT with health-related quality of life (QOL) among BMT patient-caregiver dyads.

Methods: Survey and electronic health record data were collected between April 2021 and January 2022 from BMT patients and their caregivers pre- (T1) and post-intervention (T2).

Links: Addressing Financial Toxicity Among Patients With Hematologic Cancer and Their Caregivers.

Purpose: This study examined the feasibility, acceptability, and preliminary effectiveness of an oncology financial navigation (OFN) intervention, (), among patients with hematologic cancer and their caregivers who are at increased risk of experiencing financial toxicity (FT).

Methods: All patients who presented to the Division of Hematology and Bone and Marrow Transplant (BMT) at an National Cancer Institute-designated cancer center between April 2021 and January 2022 were screened for FT during inpatient and outpatient visits. Patients who screened positive for FT and met the inclusion criteria were recruited to participate in that provided financial navigation and assistance via a financial navigator.